Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest drug half life time in humans after IV administration.
Constraint: You must select all options from a, b, c, d, or e without using any other words.
Options:
a. CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O
b. C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
c. N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1
d. O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1
e. Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
Answer: c
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
1-(3-cyano-3,3-di(cyclohexa-1,3,5-trien-1-yl)propyl]-4-piperidin-1-ylpiperidine-4-carboxamide